ReviewCureus2025
Visualizing the Global Landscape of Post-transplant Acute Lung Rejection.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
After lung transplantation, prior antibodies can rapidly attack the donor lung, causing damage and increasing acute rejection risk, specifically known as antibody-mediated rejection. While antibody matching has improved, numerous challenges remain in detecting and treating rejection. The lung's exposure to its surroundings further activates immune responses. Persistent rejection and aggressive treatments can reduce survival rates. This review is a bibliometric analysis encompassing research on lung transplants and rejection published between 2016 and 2025. Insights were obtained by extracting elements from citation analysis from the Web of Science database and outlining emerging patterns and trends using VOSviewer (version 1.6.15; Leiden University, Leiden, The Netherlands). The analysis encompasses countries, institutions, publication years, and keywords that comprise the literature on acute rejection following lung transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.